APA (7th ed.) Citation

M, B., I, S., R, H., S, B., T, J., T, M., . . . PG, R. (2022). Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA. Leukemia research, 122, 106948. https://doi.org/10.1016/j.leukres.2022.106948

Chicago Style (17th ed.) Citation

M, Beksac, et al. "Evaluation of Isatuximab in Patients with Soft-tissue Plasmacytomas: An Analysis from ICARIA-MM and IKEMA." Leukemia Research 122 (2022): 106948. https://doi.org/10.1016/j.leukres.2022.106948.

MLA (9th ed.) Citation

M, Beksac, et al. "Evaluation of Isatuximab in Patients with Soft-tissue Plasmacytomas: An Analysis from ICARIA-MM and IKEMA." Leukemia Research, vol. 122, 2022, p. 106948, https://doi.org/10.1016/j.leukres.2022.106948.